Table 3. Effect of creatine supplementation on the injured leg’s lean mass (SLM, kg) during immobilization and rehabilitation. Values are mean (± SD).
| Conditions |
Immobilization |
Rehabilotation weeks |
| Baseline |
R2 |
P value |
R4 |
R6 |
P value |
| CR group |
7.76 (.92) |
7.33 (.89) |
.001 |
7.47 (.90) |
7.74 (.91) |
.001 |
| PL group |
7.29 (.59) |
6.64 (.53) * |
.001 |
6.75 (.55) * |
6.89 (.57) * |
.001 |
* Indicates a significant difference between the CR and PL group (p < 0.05).The injured leg’s segmental lean mass (SLM; kg); prior to the immobilization (Baseline) and after acute (R2); recovery (R4) and the maintenance (R6) phase of the rehabilitation of the creatine (CR) and placebo (PL) groups. The P values refer to the treatment effect during relative immobilization and active rehabilitation
